SOURCE: UPI.com
Results from a very small study suggest that a combination of the diabetes drug Ozempic and an innovative new intestinal procedure could help erase the need for insulin in folks with Type 2 diabetes.
The procedure focuses on the duodenum, the first part of the small intestine. The duodenum is responsible for further digestion of food coming from the stomach and nutrient absorption by the body.
“ReCET is non-thermal procedure that involves delivering [via an endoscope] a pulsed electric field (PEF) to facilitate the re-cellularization of the duodenum with regenerated metabolically active cells,” he explained in a Mayo blog. “The goal of this procedure is to help individuals achieve better control of blood glucose levels by correcting how the duodenum functions.”
FULL ARTICLE HERE
